Certified Global Research Member

Key Questions Answered

Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the key challenges in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major playersâ€™ financial performance.
Evaluate strategies adopted by major players.
Recommendations

Why Choose Market Research Future?

Vigorous research methodologies for specific market.
Knowledge partners across the globe
Large network of partner consultants.
Ever-increasing/ Escalating data base with quarterly monitoring of various markets
Trusted by fortune 500 companies/startups/ universities/organizations
Large database of 5000+ markets reports.
Effective and prompt pre- and post-sales support.

Monoclonal Antibody Therapy Companies

Pioneering innovation in healthcare, Monoclonal Antibody Therapy companies specialize in developing cutting-edge treatments. Their focus lies in creating targeted therapies that leverage monoclonal antibodies, providing precision in combating diseases like cancer and autoimmune disorders, transforming the landscape of personalized medicine.

Monoclonal Antibody Therapy Key Companies

Latest Monoclonal Antibody Therapy Companies Update

FDA approves Regeneron's REGN-COV 2 (casirivimab/imdevimab) for the prevention of COVID-19 in high-risk adults and adolescents significant approval expands access to monoclonal antibody prophylaxis for vulnerable individuals, offering protection against COVID-19 infection.

Eli Lilly receives breakthrough designation for bamlanivimab and etesevimab combination for early treatment of mild-to-moderate COVID-19 FDA designation fast-tracks development and review of the therapy, highlighting its potential for early intervention against the virus.

GlaxoSmithKline enters a collaboration with iTeos Therapeutics to develop EOS-448, an anti-TIGIT monoclonal antibody for cancer treatment partnership combines GSK's expertise in immuno-oncology with iTeos' innovative technology, aiming to bring promising new cancer therapies to patients.

Amgen expands Repatha (evolocumab) indication to include treatment of heterozygous familial hypercholesterolemia (HeFH) in children aged 10 years and older approval broadens access to effective cholesterol-lowering therapy for young patients with this inherited condition.

List of Monoclonal Antibody Therapy Key Companies in the Market

Sigma-Aldrich Co. LLC

Sanofi

Pfizer Inc

Novartis AG

Merck Kae

Johnson & Johnson

GlaxoSmithKline Plc GlaxoSmithKline Plc

GenScript,

AbbVie Inc

Amgen Inc

Bayer AG

Biogen Inc

Bristol

Myers Squibb Company

Hoffmann-La Roche Ltd

Monoclonal Antibody Therapy Companies

Leading companies partner with us for data-driven Insights

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
	Single User	$ 4,950
	Multiuser License	$ 5,950
	Enterprise User	$ 7,250
Compare Licenses

Tailored for You

Dedicated Research on any specifics segment or region.
Focused Research on specific players in the market.
Custom Report based only on your requirements.
Flexibility to add or subtract any chapter in the study.
Historic data from 2014 and forecasts outlook till 2040.
Flexibility of providing data/insights in formats (PDF, PPT, Excel).
Provide cross segmentation in applicable scenario/markets.